NA20273
DNA from Fibroblast
Description:
GAUCHER DISEASE, TYPE II
GLUCOSIDASE, ACID BETA; GBA
Repository
|
NIGMS Human Genetic Cell Repository
|
Subcollection |
Heritable Diseases Lysosomal Storage Diseases |
Class |
Disorders of Lipid Metabolism |
Quantity |
10 µg |
Quantitation Method |
Please see our FAQ |
Biopsy Source
|
Unspecified
|
Cell Type
|
Fibroblast
|
Tissue Type
|
Skin
|
Transformant
|
Untransformed
|
Sample Source
|
DNA from Fibroblast
|
Race
|
White
|
Ethnicity
|
LEBANESE
|
Relation to Proband
|
proband
|
Confirmation
|
Molecular characterization before cell line submission to CCR
|
Species
|
Homo sapiens
|
Common Name
|
Human
|
Remarks
|
|
PDL at Freeze |
5.34 |
Passage Frozen |
13 |
|
IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin confirmed by LINE assay |
|
Gene |
GBA |
Chromosomal Location |
1q21 |
Allelic Variant 1 |
crossover between GBA and pseudogene; GAUCHER DISEASE, TYPE II OR III |
Identified Mutation |
RECOMBINANT (EXON 9) |
|
Gene |
GBA |
Chromosomal Location |
1q21 |
Allelic Variant 2 |
crossover between GBA and pseudogene; GAUCHER DISEASE, TYPE II OR III |
Identified Mutation |
RECOMBINANT (EXON 9) |
Remarks |
Clinically affected; fetal hydrops; hepatosplenomegaly noted prenatally; abnormal fetal movements in utero; congenital ichthyosis; infant died within 2 hours of birth; autopsy revealed colloidin-type skin, ectropia of eyes, flattened nose, absent palmar and distal pharyngeal flexure creases, flexion deformities of the left fifth finger and knee, low-set ears, hypoplastic nails and digits, massive hepatosplenomegaly, bilateral eventration of the diaphragm, ventricular septal defect, and biventricular hypertrophy; neonatal blood testing revealed thrombocytopenia, markedly raised white cell count, raised alkaline phosphatase, raised lactate and pyruvate; biopsies from all organs showed infiltration with cells characteristic of Gaucher's; leucocyte B-glucocerebrosidase activity was markedly deficient; donor subject is homozygous for a recombinant allele due to a crossover at the end of exon 9 or the beginning of intron 9 between the GBA gene and its pseudogene. |
Stone DL, Tayebi N, Orvisky E, Stubblefield B, Madike V, Sidransky E, Glucocerebrosidase gene mutations in patients with type 2 Gaucher disease. Hum Mutat15(2):181-8 2000 |
PubMed ID: 10649495 |
|
Rowlands S, Murray H, Prenatal ultrasound findings in a fetus diagnosed with Gaucher's disease (type 2) at birth Prenatal diagnosis17:765-9 1997 |
PubMed ID: 9267901 |
Gene Cards |
GBA |
Gene Ontology |
GO:0004348 glucosylceramidase activity |
|
GO:0005764 lysosome |
|
GO:0005975 carbohydrate metabolism |
|
GO:0006665 sphingolipid metabolism |
|
GO:0007040 lysosome organization and biogenesis |
|
GO:0016020 membrane |
|
GO:0016798 hydrolase activity, acting on glycosyl bonds |
NCBI Gene |
Gene ID:2629 |
NCBI GTR |
230900 GAUCHER DISEASE, TYPE II; GD2 |
|
606463 GLUCOSIDASE, BETA, ACID; GBA |
OMIM |
230900 GAUCHER DISEASE, TYPE II; GD2 |
|
606463 GLUCOSIDASE, BETA, ACID; GBA |
Omim Description |
GAUCHER DISEASE, ACUTE NEURONOPATHIC TYPE |
|
GAUCHER DISEASE, INFANTILE CEREBRAL |
|
GAUCHER DISEASE, TYPE II |
|
GD II |
|
|